Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000930413-10-003532)

Filing Details

Accession Number:: 0000930413-10-003532
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-06-22 13:00:00
Reporting Period:: 2010-06-18

Filing Date:: 2010-06-22
Accepted Time:: 2010-06-22 17:02:34
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
727510	Enzon Pharmaceuticals Inc	ENZN	Biological Products, (No Disgnostic Substances) (2836)	222372868

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1201050	A Craig Tooman	C/O Enzon Pharmaceuticals, Inc. 685 Route 202/206 Bridgewater NJ 08807	Exec Vp Finance, Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2010-06-18	140,800	$8.59	283,580	No	4	M	Direct
Common Stock	Disposition	2010-06-18	123,100	$11.25	160,480	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2010-06-18	140,800	$0.00	140,800	$8.59

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
159,200		2017-01-17	No	4	M	Direct

Footnotes

The Reporting Person used the proceeds of the disposition solely to pay the aggregate exercise price for the options and to satisfy tax obligations arising from the exercise of the options described in this Form 4.
The shares underlying the options became exercisable on or before January 17, 2009.